A DEVELOPMENTAL TIMING SWITCH PROMOTES AXON OUTGROWTH INDEPENDENT OF KNOWN GUIDANCE RECEPTORS.


Valsartan, Losartan and Irbesartan use in the USA, UK, copyright and Denmark after the nitrosamine recalls: a descriptive cohort study

Objectives To examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, copyright and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled.Design Retrospective cohort study.Setting USA, Canadian administrative healthcare data, Danish National Prescription Regist

read more

The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.

PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL).It suppresses genes expression by recruitment of a number of transcriptional repressors, resulting in differentiation block and malignant transformation of hematopoietic cells.Here, we found that mice primary hematopoietic progenitor cells (HPCs), transduced by DNA-binding-defec

read more

The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.

PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL).It suppresses genes expression by recruitment of a number of transcriptional repressors, resulting in differentiation block and malignant transformation of hematopoietic cells.Here, we found that mice primary hematopoietic progenitor cells (HPCs), transduced by DNA-binding-defec

read more